846 related articles for article (PubMed ID: 19824739)
1. Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data.
Gürcan HM; Ahmed AR
Am J Clin Dermatol; 2009; 10(6):383-96. PubMed ID: 19824739
[TBL] [Abstract][Full Text] [Related]
2. Analysis of current data on the use of methotrexate in the treatment of pemphigus and pemphigoid.
Gürcan HM; Ahmed AR
Br J Dermatol; 2009 Oct; 161(4):723-31. PubMed ID: 19548961
[TBL] [Abstract][Full Text] [Related]
3. Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid.
Gürcan HM; Ahmed AR
Ann Pharmacother; 2007 Oct; 41(10):1604-10. PubMed ID: 17785614
[TBL] [Abstract][Full Text] [Related]
4. The management of oral mucous membrane pemphigoid with dapsone and topical corticosteroid.
Arash A; Shirin L
J Oral Pathol Med; 2008 Jul; 37(6):341-4. PubMed ID: 18331284
[TBL] [Abstract][Full Text] [Related]
5. Dual diagnosis of Pemphigus and pemphigoid. Retrospective review of thirty cases in the literature.
Sami N; Ahmed AR
Dermatology; 2001; 202(4):293-301. PubMed ID: 11455140
[TBL] [Abstract][Full Text] [Related]
6. Rituximab in refractory autoimmune bullous diseases.
Schmidt E; Hunzelmann N; Zillikens D; Bröcker EB; Goebeler M
Clin Exp Dermatol; 2006 Jul; 31(4):503-8. PubMed ID: 16716150
[TBL] [Abstract][Full Text] [Related]
7. Oral lesions in patients with pemphigus vulgaris and bullous pemphigoid.
Budimir J; Mihić LL; Situm M; Bulat V; Persić S; Tomljanović-Veselski M
Acta Clin Croat; 2008 Mar; 47(1):13-8. PubMed ID: 18714642
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin therapy in autoimmune mucocutaneous blistering diseases: a review of the evidence for its efficacy and safety.
Gürcan HM; Jeph S; Ahmed AR
Am J Clin Dermatol; 2010; 11(5):315-26. PubMed ID: 20642294
[TBL] [Abstract][Full Text] [Related]
9. The management of mucous membrane pemphigoid and pemphigus.
Knudson RM; Kalaaji AN; Bruce AJ
Dermatol Ther; 2010; 23(3):268-80. PubMed ID: 20597945
[TBL] [Abstract][Full Text] [Related]
10. Treatment of pemphigus and pemphigoids.
López-Jornet P; Bermejo-Fenoll A
Med Oral Patol Oral Cir Bucal; 2005; 10(5):410-1. PubMed ID: 16264376
[No Abstract] [Full Text] [Related]
11. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.
Daoud YJ; Amin KG
Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922
[TBL] [Abstract][Full Text] [Related]
12. Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.
Heaphy MR; Albrecht J; Werth VP
Arch Dermatol; 2005 Jun; 141(6):699-702. PubMed ID: 15967915
[TBL] [Abstract][Full Text] [Related]
13. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
Mahajan VK; Sharma NL; Sharma RC; Garg G
Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
[TBL] [Abstract][Full Text] [Related]
14. Rituximab for treatment-refractory pemphigus and pemphigoid: a case series of 17 patients.
Kasperkiewicz M; Shimanovich I; Ludwig RJ; Rose C; Zillikens D; Schmidt E
J Am Acad Dermatol; 2011 Sep; 65(3):552-558. PubMed ID: 21641080
[TBL] [Abstract][Full Text] [Related]
15. High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases.
Segura S; Iranzo P; Martínez-de Pablo I; Mascaró JM; Alsina M; Herrero J; Herrero C
J Am Acad Dermatol; 2007 Jun; 56(6):960-7. PubMed ID: 17368865
[TBL] [Abstract][Full Text] [Related]
16. Treatment of bullous pemphigoid and pemphigus. The French experience, 2009 update.
Roujeau JC; Ingen-Housz-Oro S; Leroux C; Joly P
G Ital Dermatol Venereol; 2009 Aug; 144(4):333-8. PubMed ID: 19755939
[TBL] [Abstract][Full Text] [Related]
17. [Dexamethasone-cyclophosphamide pulse therapy in bullous autoimmune dermatoses].
Appelhans M; Bonsmann G; Orge C; Bröcker EB
Hautarzt; 1993 Mar; 44(3):143-7. PubMed ID: 8463094
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of azathioprine and dapsone as an adjuvant in the treatment of bullous pemphigoid.
Tirado-Sánchez A; Díaz-Molina V; Ponce-Olivera RM
Allergol Immunopathol (Madr); 2012; 40(3):152-5. PubMed ID: 21497011
[TBL] [Abstract][Full Text] [Related]
19. Rituximab in autoimmune bullous diseases: mixed responses and adverse effects.
Schmidt E; Seitz CS; Benoit S; Bröcker EB; Goebeler M
Br J Dermatol; 2007 Feb; 156(2):352-6. PubMed ID: 17223877
[TBL] [Abstract][Full Text] [Related]
20. Coexistence of pemphigus vulgaris and bullous pemphigoid in the upper aerodigestive tract.
Tabuchi K; Nomura M; Murashita H; Fujisawa Y; Tsuji S; Okubo H; Hara A
Auris Nasus Larynx; 2006 Jun; 33(2):231-3. PubMed ID: 16168587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
